| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.099 | 0.1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.065 | 0.1 |